CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

Author： Borghese Federica   Clanchy Felix IL  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.3, 2011-03, pp. : 237-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome as an Emerging Therapeutic Target in Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 471-485

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a therapeutic target in autoimmune disease

By O’Sullivan Brendan   Thompson Angus   Thomas Ranjeny  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 111-122

Informa Healthcare

Access to resources Recommend Favorite

T-bet as a possible therapeutic target in autoimmune disease

By Weigmann Benno   Neurath Markus F  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 6, 2002-12 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite

BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders

By Kalled Susan L   Ambrose Christine   Hsu Yen-Ming  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 1, 2003-02 ,pp. : 115-123

Informa Healthcare

Access to resources Recommend Favorite

The Immunoproteasome: An Emerging Therapeutic Target

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2923-2930

Bentham Science Publishers

Access to resources Recommend Favorite